- Home
- MDGL vs ARW Comparison
MDGL vs ARW Comparison
Compare MDGL & ARW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- ARW
- Stock Information
- Founded
- MDGL 2011
- ARW 1935
- Country
- MDGL United States
- ARW United States
- Employees
- MDGL N/A
- ARW N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- ARW Electronic Components
- Sector
- MDGL Health Care
- ARW Technology
- Exchange
- MDGL Nasdaq
- ARW Nasdaq
- Market Cap
- MDGL 7.4B
- ARW 6.3B
- IPO Year
- MDGL N/A
- ARW N/A
- Fundamental
- Price
- MDGL $321.33
- ARW $116.05
- Analyst Decision
- MDGL Buy
- ARW Hold
- Analyst Count
- MDGL 14
- ARW 4
- Target Price
- MDGL $347.33
- ARW $124.25
- AVG Volume (30 Days)
- MDGL 654.8K
- ARW 452.9K
- Earning Date
- MDGL 10-31-2024
- ARW 10-31-2024
- Dividend Yield
- MDGL N/A
- ARW N/A
- EPS Growth
- MDGL N/A
- ARW N/A
- EPS
- MDGL N/A
- ARW 8.98
- Revenue
- MDGL $76,813,000.00
- ARW $28,489,604,000.00
- Revenue This Year
- MDGL N/A
- ARW N/A
- Revenue Next Year
- MDGL $193.46
- ARW $1.89
- P/E Ratio
- MDGL N/A
- ARW $12.70
- Revenue Growth
- MDGL N/A
- ARW N/A
- 52 Week Low
- MDGL $168.25
- ARW $108.51
- 52 Week High
- MDGL $368.29
- ARW $137.80
- Technical
- Relative Strength Index (RSI)
- MDGL 62.52
- ARW 32.17
- Support Level
- MDGL $272.72
- ARW $112.80
- Resistance Level
- MDGL $323.99
- ARW $116.16
- Average True Range (ATR)
- MDGL 19.26
- ARW 2.30
- MACD
- MDGL -2.73
- ARW -0.43
- Stochastic Oscillator
- MDGL 48.41
- ARW 15.44
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About ARW Arrow Electronics Inc.
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.